Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala

Exclusion Criteria

• •Known immunodeficiency
• •Major congenital malformation (e.g., hemodynamically compromised congenital heart malformation or any malformation leading to recurrent pneumonia) or serious chronic disorder
• •Significant neurological disorder
• •Hospitalization within the previous 30 days for pneumonia or respiratory infection
• •Use of parenteral antibiotics for current illness (leading to diagnosis of pneumonia)
• •Transferred to the study hospital after already being hospitalized at a different location for ≥ 48 hours
• •CONTROLS:
• •Known immunodeficiency
• •Major congenital malformation (e.g., hemodynamically compromised congenital heart malformation or any malformation leading to recurrent pneumonia) or serious chronic disorder
• •Significant neurological disorder
• •Fever or suspicion of community-acquired pneumonia or other respiratory infectious disease (symptoms of cough, congestion, tachypnea, indrawing, etc.)
• •Hospitalization within the previous 30 days for pneumonia or respiratory infection